Protalix BioTherapeutics (PLX) Change in Inventory (2010 - 2026)

Protalix BioTherapeutics' Change in Inventory history runs 17 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 373.17% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $11.0 million, a 486.2% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 104.09% from the prior year.
• Change in Inventory advanced to $4.7 million in Q1 2026 per PLX's latest filing, from $4.5 million in the prior quarter.
• Across five years, Change in Inventory topped out at $4.7 million in Q1 2026 and bottomed at -$3.5 million in Q3 2024.
• The 5-year median for Change in Inventory is $124000.0 (2025), against an average of $736470.6.
• Across the five-year window, Change in Inventory sank 667.82% in 2023 and soared 373.17% in 2026, its largest moves.
• Year by year, Change in Inventory stood at $2.2 million in 2022, then sank by 213.2% to -$2.5 million in 2023, then jumped by 259.34% to $4.0 million in 2024, then increased by 10.63% to $4.5 million in 2025, then climbed by 6.06% to $4.7 million in 2026.
• Per Business Quant, the three latest PLX Change in Inventory figures stand at $4.7 million (Q1 2026), $4.5 million (Q4 2025), and $124000.0 (Q3 2025).